Comparison Overview

Zitter Insights, an MMIT Company

VS

Dr. Reddy's Laboratories

Zitter Insights, an MMIT Company

1040 Stony Hill Rd, Yardley, Pennsylvania, 19067, US
Last Update: 2026-02-12
View Profile
Between 750 and 799
https://www.mmitnetwork.com/zitter-panel/

As a trusted resource since 1989 and acquired in early 2019, Zitter Insights is a division of MMIT that brings market research and helps address the “why” of market access. Our Zitter Insights panel represents top health plans, PBMs and IDNs to provide meaningful insights to our clients.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 19
Subsidiaries: 2
12-month incidents
0
Known data breaches
1
Attack type number
1
View Profile

Dr. Reddy's Laboratories

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad, TS, IN, 500034
Last Update: 2026-04-03
Between 750 and 799
http://www.drreddys.com

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com.  Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages.  Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 31,653
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/zitter-health-insights.jpeg
Zitter Insights, an MMIT Company
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/dr--reddys-laboratories.jpeg
Dr. Reddy's Laboratories
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Zitter Insights, an MMIT Company
100%
Compliance Rate
0/4 Standards Verified
Dr. Reddy's Laboratories
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Zitter Insights, an MMIT Company in 2026.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Dr. Reddy's Laboratories in 2026.

Incident History — Zitter Insights, an MMIT Company (X = Date, Y = Severity)

Zitter Insights, an MMIT Company cyber incidents detection timeline including parent company and subsidiaries

Incident History — Dr. Reddy's Laboratories (X = Date, Y = Severity)

Dr. Reddy's Laboratories cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/zitter-health-insights.jpeg
Zitter Insights, an MMIT Company
Incidents

Date Detected: 10/2021
Type:Breach
Attack Vector: External System Breach (Hacking)
Blog: Blog
https://images.rankiteo.com/companyimages/dr--reddys-laboratories.jpeg
Dr. Reddy's Laboratories
Incidents

No Incident

FAQ

Dr. Reddy's Laboratories company demonstrates a stronger AI Cybersecurity Score compared to Zitter Insights, an MMIT Company company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Zitter Insights, an MMIT Company company has historically faced a number of disclosed cyber incidents, whereas Dr. Reddy's Laboratories company has not reported any.

In the current year, Dr. Reddy's Laboratories company and Zitter Insights, an MMIT Company company have not reported any cyber incidents.

Neither Dr. Reddy's Laboratories company nor Zitter Insights, an MMIT Company company has reported experiencing a ransomware attack publicly.

Zitter Insights, an MMIT Company company has disclosed at least one data breach, while the other Dr. Reddy's Laboratories company has not reported such incidents publicly.

Neither Dr. Reddy's Laboratories company nor Zitter Insights, an MMIT Company company has reported experiencing targeted cyberattacks publicly.

Neither Zitter Insights, an MMIT Company company nor Dr. Reddy's Laboratories company has reported experiencing or disclosing vulnerabilities publicly.

Neither Zitter Insights, an MMIT Company nor Dr. Reddy's Laboratories holds any compliance certifications.

Neither company holds any compliance certifications.

Zitter Insights, an MMIT Company company has more subsidiaries worldwide compared to Dr. Reddy's Laboratories company.

Dr. Reddy's Laboratories company employs more people globally than Zitter Insights, an MMIT Company company, reflecting its scale as a Pharmaceutical Manufacturing.

Neither Zitter Insights, an MMIT Company nor Dr. Reddy's Laboratories holds SOC 2 Type 1 certification.

Neither Zitter Insights, an MMIT Company nor Dr. Reddy's Laboratories holds SOC 2 Type 2 certification.

Neither Zitter Insights, an MMIT Company nor Dr. Reddy's Laboratories holds ISO 27001 certification.

Neither Zitter Insights, an MMIT Company nor Dr. Reddy's Laboratories holds PCI DSS certification.

Neither Zitter Insights, an MMIT Company nor Dr. Reddy's Laboratories holds HIPAA certification.

Neither Zitter Insights, an MMIT Company nor Dr. Reddy's Laboratories holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

Hirschmann EagleSDV version 05.4.01 prior to 05.4.02 contains a denial-of-service vulnerability that causes the device to crash during session establishment when using TLS 1.0 or TLS 1.1. Attackers can trigger a crash by initiating TLS connections with these protocol versions to disrupt service availability.

Published
Date
2026-04-02
Updated
Date
2026-04-02
Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
cvss4
Base: 8.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

The stored API keys in temporary browser client is not marked as protected allowing for JavScript console or other errors to allow for extraction of the encryption credentials.

Published
Date
2026-04-02
Updated
Date
2026-04-02
References
Description

XSS vulnerability in cveInterface.js allows for inject HTML to be passed to display, as cveInterface trusts input from CVE API services

Published
Date
2026-04-02
Updated
Date
2026-04-02
References
Description

Multiple reflected cross-site scripting (XSS) vulnerabilities in the login.php endpoint of Interzen Consulting S.r.l ZenShare Suite v17.0 allows attackers to execute arbitrary Javascript in the context of the user's browser via a crafted URL injected into the codice_azienda and red_url parameters.

Published
Date
2026-04-02
Updated
Date
2026-04-02
References
Description

A reflected cross-site scripting (XSS) vulnerability in the login_newpwd.php endpoint of Interzen Consulting S.r.l ZenShare Suite v17.0 allows attackers to execute arbitrary Javascript in the context of the user's browser via a crafted URL injected into the codice_azienda parameter.

Published
Date
2026-04-02
Updated
Date
2026-04-02
References